Cargando…

Ranibizumab port delivery system: a clinical perspective

Age-related macular degeneration (AMD) represents a leading cause of blindness worldwide. Neovascular AMD (nAMD) is a subtype of AMD most frequently treated with intravitreal anti-vascular endothelial growth factor (aVEGF) injections, which has allowed for patients to maintain vision that would have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichenbaum, David A, Ahmed, Abrahim, Hiya, Farhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516155/ https://www.ncbi.nlm.nih.gov/pubmed/36161829 http://dx.doi.org/10.1136/bmjophth-2022-001104

Ejemplares similares

Ranibizumab port delivery system in neovascular age-related macular degeneration
por: Chandrasekaran, Priya R., et al.
Publicado: (2022)

Therapeutic Potential of the Ranibizumab Port Delivery System in the Treatment of AMD: Evidence to Date
por: Chen, Eric R, et al.
Publicado: (2020)

The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery
por: Ranade, Shrirang V., et al.
Publicado: (2022)

Port delivery system with ranibizumab (Susvimo) recall- What does it mean to the retina specialists
por: Sharma, Ashish, et al.
Publicado: (2023)

Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2022)

Current perspectives on ranibizumab
por: Dedania, Vaidehi S, et al.
Publicado: (2015)

EVALUATION OF SURGICAL FACTORS AFFECTING VITREOUS HEMORRHAGE FOLLOWING PORT DELIVERY SYSTEM WITH RANIBIZUMAB IMPLANT INSERTION IN A MINIPIG MODEL
por: Bantseev, Vladimir, et al.
Publicado: (2020)

Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
por: Chang, Margaret A., et al.
Publicado: (2022)

Characterization of Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Ranibizumab
por: Liu, Wenqiang, et al.
Publicado: (2019)

Lasting Controversy on Ranibizumab and Bevacizumab
por: Zou, Lihui, et al.
Publicado: (2011)

A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
por: Muheem, Abdul, et al.
Publicado: (2016)

Delayed Postoperative Tension Pneumocephalus Treated With a Subdural Evacuating Port System: A Case Report and Review of the Literature
por: Laing, Brandon R, et al.
Publicado: (2022)

Ranibizumab for the treatment of degenerative ocular conditions
por: Triantafylla, Magdalini, et al.
Publicado: (2014)

Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
por: Keane, Pearse A, et al.
Publicado: (2011)

A Review of Ranibizumab for the Treatment of Diabetic Retinopathy
por: Stewart, Michael W.
Publicado: (2017)

Serial Port Complete: COM Ports, USB Virtual COM Ports, and Ports for Embedded Systems
por: Axelson, Jan
Publicado: (2007)

Endocrine causes of heart failure: A clinical primer for cardiologists
por: Khatiwada, Saurav, et al.
Publicado: (2021)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

A clinical perspective on mucoadhesive buccal drug delivery systems
por: Gilhotra, Ritu M, et al.
Publicado: (2014)

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
por: Avery, Robert L., et al.
Publicado: (2017)

Advancements in Rectal Drug Delivery Systems: Clinical Trials, and Patents Perspective
por: Rathi, Ritu, et al.
Publicado: (2022)

Treatment of age-related macular degeneration: focus on ranibizumab
por: Spitzer, Martin S, et al.
Publicado: (2008)

Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart, Michael W
Publicado: (2013)

Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
por: Wang, Luping, et al.
Publicado: (2018)

Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity
por: Patel, Samir N, et al.
Publicado: (2019)

Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
por: Ratra, Dhanashree, et al.
Publicado: (2021)

Clinical and Histopathological Effects of Intracameral Ranibizumab in Experimental Trabeculectomy
por: Azhany, Yaakub, et al.
Publicado: (2023)

Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel
por: Gerding, Heinrich, et al.
Publicado: (2015)

A perspective on magnetic core–shell carriers for responsive and targeted drug delivery systems
por: Albinali, Kholoud E, et al.
Publicado: (2019)

Bacteriophage Delivery Systems for Food Applications: Opportunities and Perspectives
por: Costa, Maria J., et al.
Publicado: (2023)

The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis
por: Danyliv, Andriy, et al.
Publicado: (2017)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
por: Demircan, Ali, et al.
Publicado: (2018)

Redox-Responsive Drug Delivery Systems: A Chemical Perspective
por: Abed, Heba F., et al.
Publicado: (2022)

A case of late-onset larynx angioedema after ranibizumab intravitreal injection: Ranibizumab-related angioedema
por: De Bernardo, Maddalena, et al.
Publicado: (2020)

Complications of central venous port systems: a pictorial review
por: Machat, Sibylle, et al.
Publicado: (2019)

Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
por: Ulldemolins, Anna, et al.
Publicado: (2021)

Single-Port versus Multiple-Port Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Fahmy, Omar, et al.
Publicado: (2021)

Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
por: Bandello, Francesco, et al.
Publicado: (2011)

Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2012)

Ranibizumab in Diabetic Macular Oedema – A Benefit–risk Analysis of Ranibizumab 0.5 mg PRN Versus Laser Treatment
por: Ziemssen, Focke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_peppfjeddh1ab34fj6f71ppnp1